CAMARILLO, Calif.--(BUSINESS WIRE)--PBS Biotech, Inc., a developer of state of the art single-use bioreactors for the fast growing biotechnology market, announced today it has signed an exclusive distribution agreement in Korea with Green Cross Medical Sciences Corp. (GCMS), a division of Green Cross Corporation, one of Korea’s largest pharmaceutical firms. Under terms of the agreement GCMS will market, sell and support the complete line of PBS Biotech single-use bioreactors for R&D and production to the more than 200 biopharma firms of the burgeoning Korean drug, vaccine and biosimilar industry.
